Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ZnAg Liquid Solution to Treat COVID-19 in Acutely Symptomatic Non-Hospitalized Participants

NCT04610138 is registered in ClinicalTrials.gov with Clene Nanomedicine as lead sponsor.

NCT NCT04610138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04610138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of ZnAg Liquid Solution to Treat COVID-19 in Acutely Symptomatic Non-Hospitalized Participants
Lead sponsor
Clene Nanomedicine
Phase
Phase 2
Overall status
Completed
Start date
June 1, 2021
Completion date
October 20, 2022
Enrollment
296 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

covid19